Michael Lee Reed is Director at Nutex Health, Inc. (NUTX). They have made 1 open-market trade across 1 company since 2023, most recently 2026-07-31.
CIK 0001922252
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NUTX | 670 | $125K |
Shares reported on the most recent Form 4, priced at the 2026-08-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NUTX | BUY | 2023-06-13 | 2023-06-15 | $0.43 | $4K | +8.6% | -5.0% | -49.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.